These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6206261)

  • 1. A cleavage product of mouse C3 adsorbable to (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140.
    Matsushita M; Sankawa U; Okuda T; Okada H; Sasaki T
    Jpn J Exp Med; 1983 Oct; 53(5):219-25. PubMed ID: 6206261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
    Honda S; Sugino H; Asano T; Kakinuma A
    Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
    Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
    Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
    Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
    Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
    Sasaki T; Abiko N; Sugino Y; Nitta K
    Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curdlan, a (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO13140, activates the alternative complement pathway by heat treatment.
    Matsushita M
    Immunol Lett; 1990 Oct; 26(1):95-7. PubMed ID: 2276766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 13C nuclear magnetic resonance study of gel-forming (1 goes to 3)-beta-d-glucans. Evidence of the presence of single-helical conformation in a resilient gel of a curdlan-type polysaccharide 13140 from Alcaligenes faecalis var. myxogenes IFO 13140.
    Saitô H; Ohki T; Sasaki T
    Biochemistry; 1977 Mar; 16(5):908-14. PubMed ID: 843521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
    Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
    J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140.
    Sasaki T; Abiko N; Nitta K; Takasuka N; Sugino Y
    Eur J Cancer (1965); 1979 Feb; 15(2):211-5. PubMed ID: 436898
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and characterization of bovine complement component C3 and its cleavage products.
    Di Carlo AL; Paape MJ; Hellman J; Lilius EM
    Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor polysaccharide-induced tumor-regressing factor in the serum of tumor-bearing mice: purification and characterization.
    Kunimoto T; Baba H; Nitta K
    J Biol Response Mod; 1986 Jun; 5(3):225-35. PubMed ID: 3723139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.
    Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL
    J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC; Jensenius JC; Svehag SE; Brandslund I
    J Clin Lab Immunol; 1983 Dec; 12(4):201-8. PubMed ID: 6198522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activity.
    Glovsky MM; Cortes-Haendchen L; Ghekiere L; Alenty A; Williams DL; Di Luzio R
    J Reticuloendothel Soc; 1983 May; 33(5):401-13. PubMed ID: 6601707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.